Managing The Coming Tsunami of Genomic and Cellular Therapy Cost and Access Issues
Penn LDI 'Cost of a Cure' Conference Convenes Top Experts Including FDA Commissioner
Penn LDI 'Cost of a Cure' Conference Convenes Top Experts Including FDA Commissioner
Analysis shows variation in supply, appointment availability, and wait times across the city
Will Take Over In January When Founder Kevin Volpp Goes on Sabbatical
Substantial costs to caregiver well-being
State Government, Academic Researchers and Insurance Industry Experts Convene to Discuss Challenges
A post from PolicyLab's 10th anniversary blog series
Cited for 'Major Contributions to the Advancement of the Medical Sciences'
New evidence that expansion reduces overdose mortality and increases treatment access
Key themes from this year's event
Executives and Researchers from 22 Health Systems Gather at Penn
A Health Affairs blog post
PDMP policies associated with 6-9% reduction in high-risk prescriptions